# Dakota Gold Corp.: financial statements, quarterly

DC · NYSE · CIK 1852353 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dc.md) · [Financials](/companies/dc/financials.md) · [Filings](/companies/dc/filings.md) · [Insiders](/companies/dc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(8.9)](/filings/0001062993-24-018974.md) | [(9.4) d](/filings/0001062993-25-005988.md) | [(8.8)](/filings/0001062993-25-008890.md) | [(9.2)](/filings/0001062993-25-014306.md) | [(10.2)](/filings/0001062993-25-016721.md) | [(6.1) d](/filings/0001104659-26-034576.md) | [(3.8)](/filings/0001104659-26-061151.md) | [(6.9)](/filings/0001104659-26-094733.md) | [(10.9)](/filings/0001062993-25-016721.md) | [(9.2) d](/filings/0001104659-26-034576.md) | [(9.0)](/filings/0001104659-26-061151.md) | [(9.2)](/filings/0001104659-26-094733.md) |
| Interest expense | $m | [0.0](/filings/0001062993-24-018974.md) | [0.0 d](/filings/0001062993-25-005988.md) | [0.0](/filings/0001062993-25-008890.md) | [0.0](/filings/0001062993-25-014306.md) | [0.1](/filings/0001062993-25-016721.md) | [(0.0) d](/filings/0001062993-25-005988.md) | [0.0](/filings/0001062993-25-008890.md) | [0.0](/filings/0001062993-25-014306.md) | [0.0](/filings/0001062993-25-016721.md) | not reported | not reported | [0.0](/filings/0001104659-26-094733.md) |
| Income tax | $m | [(0.3)](/filings/0001062993-24-018974.md) | [(0.4) d](/filings/0001062993-25-005988.md) | [(0.0)](/filings/0001062993-25-008890.md) | [(0.0)](/filings/0001062993-25-014306.md) | [(0.0)](/filings/0001062993-25-016721.md) | [0.0 d](/filings/0001104659-26-034576.md) | [0.0](/filings/0001104659-26-061151.md) | [0.0](/filings/0001104659-26-094733.md) | [0.0](/filings/0001062993-25-016721.md) | [(0.1) d](/filings/0001104659-26-034576.md) | [0.0](/filings/0001104659-26-061151.md) | [0.0](/filings/0001104659-26-094733.md) |
| Net income | $m | [(8.5)](/filings/0001062993-23-020466.md) | [(8.8) d](/filings/0001062993-25-005988.md) | [(8.6)](/filings/0001062993-25-008890.md) | [(9.2)](/filings/0001062993-25-014306.md) | [(10.1)](/filings/0001062993-25-016721.md) | [(6.0) d](/filings/0001104659-26-034576.md) | [(3.7)](/filings/0001104659-26-094733.md) | [(6.5)](/filings/0001104659-26-094733.md) | [(10.5)](/filings/0001062993-25-016721.md) | [(8.8) d](/filings/0001104659-26-034576.md) | [(8.5)](/filings/0001104659-26-094733.md) | [(8.3)](/filings/0001104659-26-094733.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001062993-24-018974.md) | not reported | [(0.10)](/filings/0001062993-25-008890.md) | [(0.10)](/filings/0001062993-25-014306.md) | [(0.11)](/filings/0001062993-25-016721.md) | not reported | [(0.04)](/filings/0001104659-26-061151.md) | [(0.06)](/filings/0001104659-26-094733.md) | [(0.09)](/filings/0001062993-25-016721.md) | not reported | [(0.07)](/filings/0001104659-26-061151.md) | [(0.06)](/filings/0001104659-26-094733.md) |
| Basic EPS | $ per share | [(0.11)](/filings/0001062993-24-018974.md) | not reported | [(0.10)](/filings/0001062993-25-008890.md) | [(0.10)](/filings/0001062993-25-014306.md) | [(0.11)](/filings/0001062993-25-016721.md) | not reported | [(0.04)](/filings/0001104659-26-061151.md) | [(0.06)](/filings/0001104659-26-094733.md) | [(0.09)](/filings/0001062993-25-016721.md) | not reported | [(0.07)](/filings/0001104659-26-061151.md) | [(0.06)](/filings/0001104659-26-094733.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.8](/filings/0001062993-23-020466.md) | [25.5](/filings/0001062993-25-005988.md) | [15.1](/filings/0001062993-24-009833.md) | [16.1](/filings/0001062993-24-014899.md) | [14.7](/filings/0001062993-24-018974.md) | [9.4](/filings/0001104659-26-034576.md) | [46.6](/filings/0001062993-25-008890.md) | [42.0](/filings/0001062993-25-014306.md) | [33.0](/filings/0001062993-25-016721.md) | [29.7](/filings/0001104659-26-094733.md) | [107](/filings/0001104659-26-061151.md) | [99.3](/filings/0001104659-26-094733.md) |
| Current assets | $m | [13.4](/filings/0001062993-23-020466.md) | [26.2](/filings/0001062993-25-005988.md) | [16.1](/filings/0001062993-24-009833.md) | [16.8](/filings/0001062993-24-014899.md) | [15.5](/filings/0001062993-24-018974.md) | [9.9](/filings/0001104659-26-034576.md) | [47.2](/filings/0001062993-25-008890.md) | [42.6](/filings/0001062993-25-014306.md) | [34.0](/filings/0001062993-25-016721.md) | [30.4](/filings/0001104659-26-094733.md) | [108](/filings/0001104659-26-061151.md) | [100](/filings/0001104659-26-094733.md) |
| Total assets | $m | [95.0](/filings/0001062993-23-020466.md) | [108](/filings/0001062993-25-005988.md) | [101](/filings/0001062993-24-009833.md) | [102](/filings/0001062993-24-014899.md) | [101](/filings/0001062993-24-018974.md) | [95.4](/filings/0001104659-26-034576.md) | [133](/filings/0001062993-25-008890.md) | [128](/filings/0001062993-25-014306.md) | [119](/filings/0001062993-25-016721.md) | [116](/filings/0001104659-26-094733.md) | [194](/filings/0001104659-26-061151.md) | [188](/filings/0001104659-26-094733.md) |
| Current liabilities | $m | [2.2](/filings/0001062993-23-020466.md) | [4.5](/filings/0001062993-25-005988.md) | [3.9](/filings/0001062993-24-009833.md) | [6.1](/filings/0001062993-24-014899.md) | [7.1](/filings/0001062993-24-018974.md) | [2.7](/filings/0001104659-26-034576.md) | [1.8](/filings/0001062993-25-008890.md) | [2.9](/filings/0001062993-25-014306.md) | [2.9](/filings/0001062993-25-016721.md) | [3.0](/filings/0001104659-26-094733.md) | [2.8](/filings/0001104659-26-061151.md) | [3.0](/filings/0001104659-26-094733.md) |
| Total liabilities | $m | [2.8](/filings/0001062993-23-020466.md) | [4.7](/filings/0001062993-25-005988.md) | [4.0](/filings/0001062993-24-009833.md) | [6.2](/filings/0001062993-24-014899.md) | [7.5](/filings/0001062993-24-018974.md) | [3.2](/filings/0001104659-26-034576.md) | [2.2](/filings/0001062993-25-008890.md) | [3.3](/filings/0001062993-25-014306.md) | [3.3](/filings/0001062993-25-016721.md) | [3.3](/filings/0001104659-26-094733.md) | [2.8](/filings/0001104659-26-061151.md) | [4.0](/filings/0001104659-26-094733.md) |
| Shareholders' equity | $m | [92.2](/filings/0001062993-24-018974.md) | [104](/filings/0001104659-26-034576.md) | [97.1](/filings/0001062993-25-016721.md) | [95.7](/filings/0001062993-25-016721.md) | [93.3](/filings/0001062993-25-016721.md) | [92.2](/filings/0001104659-26-094733.md) | [130](/filings/0001104659-26-094733.md) | [125](/filings/0001104659-26-094733.md) | [116](/filings/0001062993-25-016721.md) | [113](/filings/0001104659-26-094733.md) | [191](/filings/0001104659-26-094733.md) | [184](/filings/0001104659-26-094733.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.3) d](/filings/0001062993-24-018974.md) | [(6.0) d](/filings/0001062993-25-005988.md) | [(10.2)](/filings/0001062993-25-008890.md) | [(5.7) d](/filings/0001062993-25-014306.md) | [(8.0) d](/filings/0001062993-25-016721.md) | [(7.6) d](/filings/0001104659-26-034576.md) | [(3.9)](/filings/0001104659-26-061151.md) | [(4.6) d](/filings/0001104659-26-094733.md) | [(9.8) d](/filings/0001062993-25-016721.md) | [(7.1) d](/filings/0001104659-26-034576.md) | [(8.1)](/filings/0001104659-26-061151.md) | [(7.4) d](/filings/0001104659-26-094733.md) |
| Capital expenditure | $m | [(0.1) d](/filings/0001062993-24-018974.md) | [0.6 d](/filings/0001062993-25-005988.md) | [0.1](/filings/0001062993-25-008890.md) | [0.0 d](/filings/0001062993-25-014306.md) | [0.0 d](/filings/0001062993-25-016721.md) | [(0.0) d](/filings/0001104659-26-034576.md) | [0.0](/filings/0001062993-25-008890.md) | [0.0](/filings/0001104659-26-094733.md) | [0.1 d](/filings/0001062993-25-016721.md) | [0.1 d](/filings/0001104659-26-034576.md) | [0.1](/filings/0001104659-26-061151.md) | [0.0](/filings/0001104659-26-094733.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.0](/filings/0001062993-23-020466.md) | [73.7](/filings/0001062993-24-009833.md) | [75.9](/filings/0001062993-24-014899.md) | [78.1](/filings/0001062993-24-018974.md) | [87.4](/filings/0001062993-25-008890.md) | [87.9](/filings/0001062993-25-014306.md) | [93.6](/filings/0001062993-25-016721.md) | [97.6](/filings/0001104659-26-061151.md) | [112](/filings/0001104659-26-094733.md) | [112](/filings/0001062993-25-016721.md) | [124](/filings/0001104659-26-061151.md) | [134](/filings/0001104659-26-094733.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 134,172,991 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001104659-26-094733.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.